Viewing Study NCT05126433

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:50 AM
Ignite Modification Date: 2026-03-05 @ 6:14 AM
Study NCT ID: NCT05126433
Status: TERMINATED
Last Update Posted: 2025-02-28
First Post: 2021-11-08
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors
Sponsor: Jazz Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumor View
None Metastatic Solid Tumor View
None Urothelial Cancer View
None Poorly Differentiated Neuroendocrine Carcinomas View
None Homologous Recombination Deficient-Positive Malignancies Agnostic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lurbinectedin View
None Monotherapy View
None Urothelial cancer View
None Poorly differentiated neuroendocrine carcinomas View
None Homologous recombination deficient-positive malignancies agnostic View